Highlights Burning Rock Biotech Limited

Equities

BNR

US12233L2060

Market Closed - Nasdaq Other stock markets 18:38:30 25/06/2024 BST			5-day change	1st Jan Change
6.8 ^USD	+0.29%		-4.63%	-26.88%

05-30	Burning Rock Biotech to Work With Bayer to Increase Patient Access to Precision Cancer Medicines in China	MT
05-30	Bayer and Burning Rock Biotech Limited Collaborates to Increase Patient Access to Precision Cancer Medicines	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Burning Rock Biotech to Work With Bayer to Increase Patient Access to Precision Cancer Medicines in China	05-30	MT
Bayer and Burning Rock Biotech Limited Collaborates to Increase Patient Access to Precision Cancer Medicines	05-30	CI
Earnings Flash (BNR.L) BURNING ROCK BIOTECH Reports Q1 Revenue RMB125.6M	05-29	MT
Burning Rock Biotech Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	05-29	CI
Earnings Flash (BNR.L) BURNING ROCK BIOTECH Posts FY23 Revenue $75.7M	04-02	MT
Earnings Flash (BNR.L) BURNING ROCK BIOTECH Posts FY23 Loss $-0.90	04-02	MT
Burning Rock Biotech Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	03-28	CI
Earnings Flash (BNR) BURNING ROCK BIOTECH LIMITED Posts Q4 Revenue RMB121.1M	03-28	MT
Burning Rock Biotech Receives Nasdaq Listing Requirement Notice	01-04	MT
Burning Rock Biotech Gets Non-Compliance Notice From Nasdaq	01-04	MT
Burning Rock Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-30	CI
Burning Rock, Boehringer Ingelheim Unveil Agreement Targeting Oncology Companion Diagnostics	30/10/23	MT
Burning Rock and Boehringer Ingelheim Achieves Master Service Agreement in Oncology Companion Diagnostics	30/10/23	CI
Burning Rock Biotech Receives Breakthrough Device Designation in China for Multi-cancer Test	16/10/23	MT
Burning Rock Biotech Limited Receives Breakthrough Device Designation from China?s NMPA for its Multi-Cancer Early Detection Test	16/10/23	CI
Earnings Flash (BNR.L) BURNING ROCK BIOTECH Reports H1 Revenue RMB288.8M	31/08/23	MT
Earnings Flash (BNR.L) BURNING ROCK BIOTECH Posts H1 Loss RMB-3.09	31/08/23	MT
Burning Rock Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	31/08/23	CI
Burning Rock Biotech Q1 Loss Narrows as Revenue Rises	30/05/23	MT
Earnings Flash (BNR.L) BURNING ROCK BIOTECH Reports Q1 Revenue RMB142.5M	30/05/23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Burning Rock Biotech Limited

Equities

BNR

US12233L2060

Highlights

Filters